MRSA strains: HA-MRSA, CA-MRSA and livestock MRSA explained
MRSA isn't one bug. Public-health labs sort it by where it spreads (hospital vs community vs livestock) and by genetic lineage — the sequence type, the SCCmec cassette it carries, and whether it makes the PVL toxin. Those distinctions change how it presents and how it's treated.
The three epidemiological groups
MRSA is usually first grouped by setting — where people pick it up and who it typically affects. These groups overlap increasingly, but the distinction still guides empirical antibiotic choice and infection-control policy.
HA-MRSA — healthcare-associated
Acquired in hospitals, nursing homes, dialysis units and long-term care. Affects older or debilitated patients with catheters, surgical wounds or prolonged admissions. Typically carries SCCmec types II or III and is resistant to several antibiotic classes beyond the beta-lactams. Common syndromes are bloodstream infection, ventilator-associated pneumonia and prosthetic-device infection.
CA-MRSA — community-associated
Spreads outside healthcare — in households, gyms, prisons, military barracks and sports teams. Affects otherwise healthy people and causes painful skin and soft-tissue abscesses that are often mistaken for spider bites. Carries the smaller SCCmec types IV or V, and many strains (notably USA300) make the Panton-Valentine leukocidin (PVL) toxin. Often still susceptible to doxycycline, clindamycin or TMP-SMX.
LA-MRSA — livestock-associated
Reservoir is farm animals — pigs, cattle and poultry — with ST398 dominant in Europe and ST9 in parts of Asia. Farm and abattoir workers are colonised at high rates but usually without symptoms. Human-to-human transmission is inefficient, and invasive disease is uncommon compared with HA- or CA-MRSA.
Major clonal lineages
Underneath the HA/CA/LA labels sits a smaller number of clones — genetically related lineages that have spread successfully around the world. They are named either by American CDC pulsotype (USA300, USA100), by European surveillance label (EMRSA-15, EMRSA-16) or by multi-locus sequence type (ST239, ST398).
| Strain | Sequence type | Group | Region | Notable features |
|---|---|---|---|---|
| USA300 | ST8 | CA-MRSA | North America (global) | PVL+, SCCmec IV, dominant community strain, skin & soft-tissue infections |
| USA400 | ST1 | CA-MRSA | North America | Earlier community outbreaks (MW2), now largely displaced by USA300 |
| USA100 | ST5 | HA-MRSA | North America | Classic hospital clone, SCCmec II, multi-drug resistant |
| USA500 | ST8 | HA / CA | North America | Ancestor of USA300, hospital and community disease |
| EMRSA-15 | ST22 | HA-MRSA | UK, Europe, global | Dominant UK hospital clone, SCCmec IV, usually PVL-negative |
| EMRSA-16 | ST36 | HA-MRSA | United Kingdom | Widespread in UK hospitals 1990s–2000s, now in steep decline |
| ST239 | ST239 | HA-MRSA | Asia, South America, E. Europe | Highly multi-drug resistant hospital clone, SCCmec III |
| ST398 | ST398 | LA-MRSA | Europe (global) | Livestock reservoir (pigs, cattle, poultry); farm-worker colonisation |
| ST80 | ST80 | CA-MRSA | Europe, Middle East, N. Africa | PVL+, SCCmec IV, community skin infections |
| ST93 | ST93 | CA-MRSA | Australia | 'Queensland clone', PVL+, dominant Australian community strain |
The genetics behind the labels
SCCmec cassette
The staphylococcal cassette chromosome mec (SCCmec) is a mobile piece of DNA that carries the mecA gene — the source of methicillin resistance. At least fourteen SCCmec types are described. Types I–III are large and typical of HA-MRSA; types IV and V are smaller, spread more easily, and dominate CA-MRSA lineages such as USA300 and ST80.
PVL — Panton-Valentine leukocidin
PVL is a two-component pore-forming toxin that punches holes in white blood cells. PVL-positive MRSA — including USA300, ST80 and ST93 — causes more aggressive skin abscesses, recurrent boils and the rare but often-fatal necrotising pneumonia seen in previously healthy young adults after influenza.
VISA and VRSA
Vancomycin is the workhorse IV antibiotic for serious MRSA. VISA (vancomycin-intermediate S. aureus) shows reduced susceptibility to vancomycin and is uncommon but real. VRSA (full vancomycin resistance, via the vanA gene borrowed from enterococci) has been reported in fewer than 20 patients worldwide since 2002 and is tracked closely by public-health labs.
Why strain identification matters
- Empirical antibiotic choice. CA-MRSA often responds to oral agents such as doxycycline, clindamycin or TMP-SMX; HA-MRSA and ST239 usually need IV vancomycin, daptomycin or linezolid.
- Outbreak tracing. Whole-genome sequencing of isolates from a ward or a household can confirm whether cases share a source, or whether they were acquired independently.
- Infection-control precautions. Detection of PVL-positive or livestock-associated strains triggers different screening, decolonisation and isolation policies in many health systems.
- Research targets. Vaccine and monoclonal- antibody candidates in development are often directed at surface proteins or toxins that vary between lineages — USA300 in particular is a common benchmark.
Related
Back to what MRSA bacteria is, or read about how MRSA spreads, how it is treated and current research.